Garnett W R, Prescott J
Virginia Commonwealth University, Medical College of Virginia School of Pharmacy, Richmond, Virginia, USA.
Manag Care Interface. 2000 Sep;13(9):71-6, 79.
Proton pump inhibitors, the treatment of choice for acid-related disorders, are often coadministered with other medications, sometimes with potentially adverse interactions. Although all agents studied may potentially interact with one proton pump inhibitor or another, a literature review documented adverse interactions for 10 medications in particular. Furthermore, 44% of people using proton pump inhibitors received another gastrointestinal drug. Although documented interactions involving these agents have been reported infrequently, the authors advise that physicians and pharmacists should recognize this possibility and watch for potentially problematic combination therapy.
质子泵抑制剂是治疗酸相关疾病的首选药物,常与其他药物联合使用,有时会产生潜在的不良相互作用。尽管所有研究的药物都可能与一种或另一种质子泵抑制剂发生相互作用,但文献综述特别记录了10种药物的不良相互作用。此外,44%使用质子泵抑制剂的人还服用了另一种胃肠道药物。尽管涉及这些药物的相互作用报道较少,但作者建议医生和药剂师应认识到这种可能性,并留意潜在的有问题的联合治疗。